Valcivir® 500 contains valacyclovir, an antiviral prodrug that is rapidly converted into acyclovir after absorption. It works by inhibiting viral DNA replication, helping to reduce viral multiplication and limit the progression of susceptible herpes virus infections.

The medication is widely used for the treatment of herpes simplex virus (HSV-1 and HSV-2) infections, shingles (herpes zoster), and chickenpox (varicella). It is also commonly prescribed for long-term suppressive therapy to reduce recurrent herpes outbreaks and decrease viral shedding in appropriate clinical situations.

Valacyclovir offers improved oral bioavailability compared with acyclovir, allowing convenient dosing while maintaining effective antiviral activity. Treatment decisions, dosing schedules, and duration of therapy should always be determined by a qualified healthcare professional.